Th17 pathway in recent-onset autoimmune diabetes

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• T helper 17 (Th17) cells and their cytokine interleukin-17A (IL-17A) are implicated in autoimmune diseases.
• The precise role of the IL-17 pathway in the pathogenesis of Type 1 diabetes (T1D) in humans remains unclear.

Purpose of the Study:

• To investigate the involvement of the IL-17 pathway in T1D pathogenesis.
• To compare IL-17 Receptor A (IL-17RA) expression on peripheral T lymphocytes and serum IL-17A levels in recent-onset T1D patients versus healthy controls.
• To analyze IL-17A gene variants for association with T1D susceptibility.

Main Methods:

• Flow cytometry was used to measure IL-17RA expression on CD3+, CD4+, and CD8+ T cells.
• Serum IL-17A levels were quantified.
• IL-17A gene coding and intron boundary regions were sequenced to identify allelic variants.
• Statistical analyses were performed to compare groups and assess correlations.

Main Results:

• Patients with recent-onset T1D showed significantly lower IL-17RA expression on CD3+ and CD4+ T cells compared to controls.
• IL-17RA expression on CD8+ T cells and serum IL-17A levels did not differ between groups.
• Seventeen IL-17A allelic variants, including three novel ones, were identified, but none were associated with T1D susceptibility.
• IL-17RA expression did not correlate with metabolic parameters (glucose, HbA1c) or autoantibody titers.

Conclusions:

• Reduced IL-17RA expression on T cells in recent-onset T1D suggests a diminished IL-17A-mediated immune response in peripheral tissues.
• IL-17A gene variants and haplotypes are not associated with T1D susceptibility in the studied cohort.